Bringing a new product to market is high stakes. Despite years of research and millions invested, too many launches fall short because the product or messaging doesn’t fully align with patient needs. The best way to avoid this? Involve patients early and often.
That’s where advisory boards come in. But not all advisory boards are created equal.
Beyond Panels and Panel Providers
Traditional panel providers build databases of individuals who are contacted when research opportunities arise. These respondents often participate in multiple panels, and their engagement is transactional. While panels can deliver quick responses, they don’t always provide the authentic, lived experience that drives better decision-making.
Inspire takes a different approach. We’re not a panel—and we don’t run a panel business. Instead, our patient advisory boards are made up of engaged members from our condition-specific communities. These are people who regularly connect with peers, share their experiences, and seek reliable information. Their input isn’t just a survey response—it’s grounded in lived reality.
How Advisory Boards De-Risk Launches
By convening advisory boards within Inspire communities, sponsors gain:
-
Authentic feedback on product positioning
Patients highlight what resonates, what confuses, and what could be misinterpreted.
-
Insights into real-world usage barriers
From dosing schedules to packaging, patients surface obstacles that may not appear in clinical data.
-
Validation of support needs
Advisory boards help identify what resources or programs patients will expect alongside a new product.
-
Message testing in context
Feedback is informed by the community environment, giving sponsors a sense of how messaging will land in real-world conversations.
This upfront validation allows sponsors to refine strategies before launch, reducing the risk of wasted spend or poor adoption.
The Inspire Advantage
Depth of engagement
Our members are not one-time respondents; they are active participants in ongoing discussions.
Breadth of access
Over 10 million patients and caregivers across 3,000+ disease states means sponsors can source diverse, representative perspectives.
Recontactability
Because members are part of a sustained community, they can be engaged longitudinally: before, during, and after launch.
Bottom Line
A product launch should never be a guessing game. By engaging advisory boards within authentic patient communities, sponsors can anticipate risks, validate assumptions, and build strategies that resonate from day one.
With Inspire, advisory boards aren’t just a checkbox—they’re a way to embed the patient perspective into every launch decision.